USPTO serial 87147817
- HEEL HEALTHCARE DESIGNED BY NATURE
Reviewed by CopyMark Law Group
Reg. 5377667Status 710
- Filing date
- Status date
- Registration date
- Jan 16, 2018
- Examiner
- TENG, SIMON
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with - HEEL HEALTHCARE DESIGNED BY NATURE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Biologische Heilmittel Heel Gmbh
Deutschland, DE
Biologische Heilmittel Heel Gmbh
Deutschland, DE
Biologische Heilmittel Heel Gmbh
Deutschland, DE
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Donna J. Bunton
DONNA J. BUNTON NIXON & VANDERHYE P.C.901 NORTH GLEBE ROAD, 11TH FLOORARLINGTON, VA 22203UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations, namely, homeopathic drugs useful for the treatment of dermatoses, keratosis, scrofulosis, boils, papular exanthema, abscesses, carbuncles, suppuratons, rashes, styes, warts, ulcerations, acne, viscular and pustular skin affections, inflamation of the skin and mucuous membranes, bedsores, gingivitis, dermatitis, eczema, pruritus psoriasis, fissures, dry skin, rhagades and fissures, cyanosis, thrush, erysipealas, ichthyosis, paresthesia, paronychia, erythema, nosodum, burns, wounds, contusions, scars and keloids, pityriasis, pemphigus, hives, excessive or malodorous perspiration, herpetic and sycotic complaints, alopecia, exanthema of the scalp, neural and cerebral injuries, convulsions, epilepsy, apoplectic attacks, migraine, cephalagia, headaches, tics, paralysis, multiple sclerosis, collapse, shocks, dizziness, hypothermia, vagotonia, meningitis, neuralgia, scratica, lumbago, ganglia, paresis, chorea, insomnia, exhaustion, debility, stupor, depression, anxiety, neurasthemia, restlessness, irritability, deficient memory, confusional states, hysteria, photophobia, agoraphobia, hypersensitivity, speech disorders, eye inflammations and eye pain, conjunctivitis, blepharitis, dacryocrystitis, senile, cataracts, chemosis, iritis rheumatica, keratitis, asthenopia, earache, ringing and humming in the ears, meniere's syndrome, otitis, stomatitis, clossitis, rhinitis, polysinusitus, nasal polyps, absence of sense of smell, azaena, angina, tonsillitis, swollen tonsils, hoarseness, laryngitis, pharyngitis, choking sensation in the throat, catarrhs and inflamation of the respiratory tract, coughs, tussive irritation, shortness of breath and lung congestion, chest pain, hay fever, asthma, emphysema, bronchitis, bronchiolitis, bronchiectasis, pleuritis, haemoptysis, myocardial weakness, cardiac pains, aortic aneurysm, stenocordia, weak pulse, coronary insufficiency, hypertonic heart, cor nervosum, arrhythmia cordis, poricarditis and endocarditus, circulatory disorders, pyrosis, pseudohemophilia, aenemia, acetonaemia, hemorrhages tendency towards bleeding, hypertension, anasarca,varicose veins, venous stasis, telangiecstasis, phlebitis, edemas and dropsy, ascites, arteriosclerosis, disorders of the lymphatic system, swelling of the lymph glands, struma, cysts, tumors, myomas, haematomas, cystistis and cystalgia, adenosclerosis, hyperthyroidism, glandular tumors, lymphadenitis, goitre, helminthiasis, causalgia, muscular tension, contractions, and cramps, muscular atrophy, torticollis, muscle spasms and pain, rickets, toothache, dental caries, disorders of dentition, fractures, fistulae on bones, osteochrondosis, ostealgia, spondylarthrosis, causalgia and disorders arising from amputation stumps, myelitis, arthrosis, arthritis, rheumatism, coxitis, fibrositis, crepitation of the joints, spasma, dislocations, tennis elbow, tendonitis and tondosynovitis, inflammation of the joints, pain, fever, septic conditions, gangrene, typhoid fever, scarlet fever, rubella, whopping cough, pneumonia, influenza, mumps, viruses, sunstroke, shingles, ringworm, trichomonas fluor, septicemia, diabetes, anoxeria, emaciation, dyspepsia, nausea, intolerance to milk or alcohol, vomiting, hyperacidity, stomach cramps, colic, gastralgia, gastitus, gastroenteritis, gastic hemorrhages, pyrosis, enteritis, gastro-intestinal spasms, abdominal plethora, meteorism, flatulence, colitis, diarrohaea, constipation, duodenitis, duodenal ulcers, haemorrhoids, anal fissures, hepatitis, liver disorders, splenic disorders, pancreatitis, pancreopathy, biliary colic, gallbladder disorders, gallstones, abdominal soreness, nephrosis, nephritis, nephroliathsis, disorders of the intermediary uric acid metabolism, urinary disorders, strangury, urethritis, incontinence, albuminaria, renal and bladder pains, oxaluria, vesical tenesmus, dysury, consequences of excessive alcohol consumption or drug usage, prostatic adenoma, prostatis, impotence, epidymitis, mastoiditis, cervical syndrome, ovaritis, ovarian cysts, metritis, prolasped uterus, menorrhagia, metrorrhagia, dysmenorrhoea, amenorrhoea, leucorrhoea, excessive or insufficient lactation, mastopathy, hot flushes, menopause, fluoralbus, allergies, precancerous conditions, disorders and pain arising from ulcerations in carcinoma, syphillis and lupus, traumatism resulting from falls, werlhof's disease, cachexia, adiposity, hydrogenoid constitution, active hyperacemia, and scheuermann's disease; veterinary preparations, namely, homeopathic drugs useful for the treatment of chronic diseases, coronary circulation system, dermatology digestive system, gerontology, greater defense system, musculoskeletal system, nervous and sensorical system, renal system, reproductive system and respiratory system in animals; dietetic substances, namely, dietetic food adapted for medical use | SECTION 8 - CANCELLED | — |
| 044 | Providing information, consultancy and advisory services in the fields of medicine, health, healthcare and the diagnostic, prophylactic and therapeutic properties of homeopathic pharmaceuticals; medical services; veterinary services; hygienic and beauty care for human beings or animals | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Biologische Heilmittel Heel Gmbh
- Other trademarks owned by Biologische Heilmittel Heel Gmbh
- Other trademarks owned by Biologische Heilmittel Heel Gmbh
- Other trademarks in Class 005
- Other trademarks in Class 044
- Similar marks named - HEEL HEALTHCARE DESIGNED BY NATURE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 26, 2024 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Jan 16, 2023 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Jan 16, 2018 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 31, 2017 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 31, 2017 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 11, 2017 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 22, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 22, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 12, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 11, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 11, 2017 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| May 15, 2017 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| May 15, 2017 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| May 15, 2017 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Apr 14, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 14, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 12, 2017 | ALIE | ASSIGNED TO LIE | — |
| Mar 28, 2017 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 28, 2016 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 28, 2016 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 28, 2016 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 28, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 27, 2016 | MDSM | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Aug 26, 2016 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 26, 2016 | NWAP | NEW APPLICATION ENTERED | — |